Determinants of HPV vaccine hesitancy in Europe
8
Emilie Karafillakis Vaccine Confidence Project London School of Hygiene & Tropical Medicine [email protected] Determinants of HPV vaccine hesitancy in Europe Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus Vaccination London, 7-8 June 2017 1
Transcript of Determinants of HPV vaccine hesitancy in Europe
Emilie KarafillakisVaccine Confidence ProjectLondon School of Hygiene & Tropical [email protected]
Determinants of HPV vaccine hesitancy in Europe
Building Trust, Managing Risk: Vaccine Confidence and Human Papillomavirus Vaccination
London, 7-8 June 2017
1
A focus on Europe
2
Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016).
A focus on Europe
3
• Europe - lowest confidence in vaccine safety in the world (~17%)
• Series of critical events due to low HPV confidence
• Important differences between countries (transnational influences)
Systematic review to understand reasons for low confidence in HPV vaccination in Europe
Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016).
17
37
31
17
6
1614
7
1618
2211
49%
40%
38%
35%
30%
27%
24%
17% 16%15%
12%
9%
0%
10%
20%
30%
40%
50%
60%
0
10
20
30
40
50
60
Mistrust Side effects Informationissues
Decisionmaking
(parents)
Logisticalbarriers (cost)
Loweffectiveness
Influencers Against all ortoo manyvaccines
No necessityor risk
Age issues Moralityissues
Fear ofinjections
Num
ber
of
stu
die
s
Qualitative Quantitative
Determinants of HPV vaccine hesitancy in Europe
4
PRELIMINARY RESULTS (ECDC TECHNICAL REPORT, 2017)
Uncertaintyat the heart of HPV vaccine hesitancy
Uncertainty
5
Mistrust
Low confidence/trust in HPV vaccination
Information
PRELIMINARY RESULTS (ECDC TECHNICAL REPORT, 2017)
Other important points
• Vaccine safety remains a key issue
• Differences between countries (Italy/France vs UK), lack of research in Eastern Europe
• Different issues than other vaccines: role of decision-making, morality, uncertainties, rumours spread in schools
• Scientific literature does not capture concerns in real time need for fast data tools (e.g. media monitoring)
6
PRELIMINARY RESULTS (ECDC TECHNICAL REPORT, 2017)
Need strategies to address HPV vaccine confidence in a “post-fact” world
Emilie KarafillakisVaccine Confidence ProjectLondon School of Hygiene & Tropical [email protected]
